EODData

NASDAQ, PTGX:

08 Sep 2025
LAST:

56.19

CHANGE:
 4.34
OPEN:
59.50
HIGH:
59.50
ASK:
11.00
VOLUME:
1.64M
CHG(%):
7.17
PREV:
60.53
LOW:
54.60
BID:
6.74
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Sep 2559.5059.5054.6056.191.64M
05 Sep 2559.3461.0458.0360.531.93M
04 Sep 2558.2260.7157.4559.601.47M
03 Sep 2558.2559.5157.4958.111.02M
02 Sep 2559.4059.7558.2758.85665.8K
29 Aug 2558.5059.2857.6659.05792.2K
28 Aug 2561.4661.8958.0758.141M
27 Aug 2556.7161.5056.7161.431.43M
26 Aug 2557.2857.5056.5856.99516.4K
25 Aug 2557.4858.7956.5656.88544.9K

COMPANY PROFILE

Name:
About:Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Sector:Healthcare
Industry:Biotechnology
Address:7707 Gateway Boulevard, Newark, CA, United States, 94560
Website:https://www.protagonist-inc.com
CUSIP:74366E102
CIK:0001377121
ISIN:US74366E1029
FIGI:BBG002B63KM7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:77.05
Price to Book:5.24
Price to Sales:16.73
EBITDA:24.87M
Shares:62.21M
Market Cap:3.496B

TECHNICAL INDICATORS

MA5:58.66
MA10:58.58
MA20:57.20
MA50:55.08
MA100:51.84
MA200:46.96
STO14:2.56
RSI14:49.95
WPR14:-97.22
MTM14:-0.06
ROC14:0.00
ATR:2.51
Week High:61.04
Week Low:54.60
Month High:61.89
Month Low:50.49
Year High:61.89
Year Low:33.31
Volatility:6.74